@article{3122230,
    title = "Neonatal screening for congenital CMV infection stresses the importance of maternal nonprimary infection even in an area where prenatal serology testing is common",
    author = "Papaevangelou, V. and Christoni, Z. and Vliora, C. and Kottaridi, C. and Fotiou, A. and Malamitsi-Puchner, A. and Mentis, A. and Karakitsos, P. and Syggelou, A.",
    journal = "Journal of Maternal-Fetal and Neonatal Medicine",
    year = "2019",
    volume = "32",
    number = "11",
    pages = "1901-1904",
    publisher = "Taylor and Francis Ltd.",
    issn = "1476-7058, 1476-4954",
    doi = "10.1080/14767058.2017.1416605",
    keywords = "Cytomegalovirus antibody;  immunoglobulin G, adult;  Article;  asymptomatic infection;  cohort analysis;  congenital infection;  controlled study;  cytomegalovirus infection;  dried blood spot testing;  female;  human;  incidence;  major clinical study;  male;  newborn;  newborn screening;  perception deafness;  prenatal care;  priority journal;  serology;  asymptomatic infection;  case report;  cytomegalovirus infection;  Greece;  pregnancy;  prevalence, Adult;  Asymptomatic Infections;  Cohort Studies;  Cytomegalovirus Infections;  Female;  Greece;  Humans;  Infant, Newborn;  Pregnancy;  Prevalence",
    abstract = "Aim and Methods: Dried blood spots from 2149 newborns were examined to diagnose congenital cytomegalovirus (cCMV). Results: Prenatal CMV-IgG antibodies had been measured during prenatal care in 1287 (60.3%) of mothers and 980 (76.1%) of them were found seropositive. cCMV incidence was 0.47%. All newborns were asymptomatic; 9/10 were born post nonprimary maternal infection; two developed sensorineural hearing loss. Conclusions: In a country where prenatal CMV testing is common and therefore a false sense of control might prevail, nonprimary maternal infection should not be overlooked. Indeed, women of childbearing age should be educated on CMV prevention measures irrespectively to their serostatus. © 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group."
}